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Abstract
Long-term memory (LTM) formation requires new protein synthesis and new gene expression. Based on our work in Aplysia,
we hypothesized that the rRNA genes, stimulation-dependent targets of the enzyme Poly(ADP-ribose) polymerase-1 (PARP-
1), are primary effectors of the activity-dependent changes in synaptic function that maintain synaptic plasticity and
memory. Using electrophysiology, immunohistochemistry, pharmacology and molecular biology techniques, we show here,
for the first time, that the maintenance of forskolin-induced late-phase long-term potentiation (L-LTP) in mouse
hippocampal slices requires nucleolar integrity and the expression of new rRNAs. The activity-dependent upregulation of
rRNA, as well as L-LTP expression, are poly(ADP-ribosyl)ation (PAR) dependent and accompanied by an increase in nuclear
PARP-1 and Poly(ADP) ribose molecules (pADPr) after forskolin stimulation. The upregulation of PARP-1 and pADPr is
regulated by Protein kinase A (PKA) and extracellular signal-regulated kinase (ERK)—two kinases strongly associated with
long-term plasticity and learning and memory. Selective inhibition of RNA Polymerase I (Pol I), responsible for the synthesis
of precursor rRNA, results in the segmentation of nucleoli, the exclusion of PARP-1 from functional nucleolar compartments
and disrupted L-LTP maintenance. Taken as a whole, these results suggest that new rRNAs (28S, 18S, and 5.8S ribosomal
components)—hence, new ribosomes and nucleoli integrity—are required for the maintenance of long-term synaptic
plasticity. This provides a mechanistic link between stimulation-dependent gene expression and the new protein synthesis
known to be required for memory consolidation.
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Introduction
More than half a century has passed since it was first noted that
LTM formation requires new protein synthesis [1] and new gene
expression [2] (reviewed by [3])—ideas that transformed the field
of learning and memory by propelling it into the arena of
molecular genetics. Additionally, persistent forms of synaptic
plasticity such as long-term facilitation (LTF) in invertebrates and
long-term potentiation (LTP) in mammals have provided valuable
models for investigating the molecular mechanism that underlies
memory formation, consolidation and maintenance [3,4].
Significant progress has been made toward understanding the
molecular events that initiate the translational and genomic
response to synaptic stimulation [5–7]. For reviews see [8,9]. Still,
relatively little is known about the mechanism whereby activity-
induced transcription is coupled to selective translation in order to
perpetuate synapse specific changes.
Most efforts to understand experience-induced changes in
neuronal gene expression have focused on the transcription
products of RNA polymerase II (precursor mRNA, snRNA and
microRNA). Yet, the identities of the gene products that are both
necessary and sufficient to consolidate activity-dependent, long-
term plastic changes have remained elusive.
We and others have shown that the chromatin-remodeling
enzyme, PARP-1, is an important epigenetic regulator of gene
expression required for synaptic plasticity and memory in
invertebrates and mammals [10–13]. In Aplysia, we found that
PARP-1 is necessary for LTF, and that among the activity-
dependent genes upregulated by PARP-1 were ribosomal RNA
genes (rDNA) [11]. Transcription of rDNA is carried out by RNA
polymerase I (Pol I) in the nucleolus, a dynamic intranuclear
organelle where rRNA synthesis, processing, and ribosome
assembly take place. PARP-1 is abundant in the nucleolus and
has been shown to be essential for the inheritance of rDNA
chromatin organization [14], as well as the processing of pre-
rRNAs and their assembly into ribosomes [15]. Based on these
findings, we hypothesized that crucial among the new gene
products required for LTP are new rRNA components of the
translational machinery itself, and that this activity-dependent
gene expression is modulated by PARP-1. Here we report that
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nucleolar integrity and new rRNA gene expression are required
for the maintenance of LTP in mouse hippocampal slices, and that
this inducible transcriptional activity of Pol I is regulated by PKA/
ERK-dependent PAR.
Materials and Methods
Drugs
3- aminobenzamide (3-AB; Sigma, St. Louis, MO) was used to
inhibit PAR (Figs. 1, 2 D,E and 3). Actinomycin-D (Act-D; ICN
Biomedicals, Aurora, OH) was used to inhibit RNA polymerase I
(Pol I) directed rRNA transcription (Figs. 4, 5, 6, and S2). CX-
5461 (Selleckchem, Houston, TX) was used to inhibit Pol I
(Fig. 7). Forskolin (Fsk; Calbiochem, La Jolla, CA) was used to
evoke a form of long-term potentiation (LTP) (Figs. 2, 3, 6, 8, and
9). Specific kinase inhibitors KT5720 (Sigma) and U0126 (Sell-
eckchem, Houston, TX) were used to block PKA and ERK
kinases (Fig. 8 and 9, respectively). All the drugs (stock solutions)
were dissolved in dimethyl-sulfoxide (DMSO). Whenever DMSO
was used, the final concentration never exceeded 0.05% (v/v).
Animal preparations
All procedures were approved by the Institutional Animal Care
and Use Regulations of SUNY Downstate Medical Center.
Cultured neurons (Figs. 1A–G, 4, 7A–I, and S2). Primary
hippocampal neurons were prepared from Sprague-Dawley E18/
19 rats (Hilltop), according to the method described by Brewer and
collaborators (1993) [16] and were utilized after 14 to 18 days in
vitro.
Hippocampal slice preparation (Figs. 2, 3, 5, 6, 7L–O, 8,
and 9). Adult (2–4 months old) male C57BL6 mice (Taconic
Farms) were transferred from the home cage to the anesthetizing
chamber and remained in the covered chamber for 15–20 min for
acclimation. Subsequently, animals were deeply anesthetized with
5% vaporized isoflurane in oxygen (100%) for 2–3 min and
euthanized via decapitation. The brain was removed and rapidly
transferred to ice cold, oxygenated (95% O2, 5% CO2) dissection
artificial cerebrospinal fluid (dACSF, containing in mM: 125
NaCl, 2.5 KCl, 0.5 CaCl2, 7 MgSO4, 1.25 NaH2PO4, 25
NaHCO3, and 10 Glucose; pH 7.4) and both hippocampi were
dissected out. Isolated hippocampi were transversally sliced with a
pre-chilled manual tissue chopper (MyNeurolab.com, USA) to
produce 400 mm sections. The slices were rapidly transferred to a
beaker with oxygenated recording ACSF (rACSF, containing in
mM: 125 NaCl, 2.5 KCl, 2 CaCl2, 1 MgSO4, 1.25 NaHPO4, 25
NaHCO3, 25 Glucose) at 35uC for 45 min and then left to recover
at room temperature for at least 60 min. After recovery slices were
transferred to a recording interface chamber for electrophysiology
experiments (to detect LTP expression) or underwent different
treatments (see treatments of hippocampal slices for immunohis-
tochemistry, Real-time PCR and Western blot analyses).
Electrophysiology
Transverse hippocampal slices (400 mm) were incubated in an
interface chamber at 34–35uC, subfused with oxygenated rACSF,
and allowed to equilibrate for at least 60 min. Field excitatory
postsynaptic potentials (fEPSPs) were recorded at CA3/Schaffer
collateral-CA1 synapses by placing both stimulating and recording
electrodes in the stratum radiatum of the CA1 area. The
Figure 1. PAR inhibitor 3-AB produces changes in nucleolar fibrillarin intensity in cultured hippocampal neurons. DAPI staining (blue;
A, B, G and H) shows the area of nuclei. Nomarski images (grey; E and F) show the area of the nuclei and nucleoli (arrowheads). (I) 3-AB treatment
(100 mM, 3h) has no effect on the average area of the nucleolar marker fibrillarin (green). (J) In contrast, there was an increase in the average intensity
of fibrillarin that was,1.6 fold stronger than control; compare arrowheads A,C,G to B, D,H. Bar = 10 mm (A–F) and 2 mm (G, H). Student’s t-test ** = p,
0.01; NS = not significant.
doi:10.1371/journal.pone.0104364.g001
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stimulation intensity (square pulse, 50 msec duration) was adjusted
to give fEPSP slopes of approximately 40% of maximum. Baseline
and after-stimuli responses were sampled once per min at this
intensity for the duration of the experiment. In order to assess the
effect of PAR inhibition on the late stages of LTP (Fig. 2D, E), 3-
AB (100 mM) was administered 30 min after LTP–eliciting Fsk
treatment (50 mM, 30 min) for 45 min duration. In order to assess
the effect of Pol I inhibition on LTP, a low concentration (100 nM)
of Act-D (Fig. 6) or (200 nM) CX-5461 (Fig. 7L,M) was added to
slices 15 min prior to Fsk treatment and was maintained for the
duration of the treatment (45 min total). None of the drugs (3-AB,
Act-D nor CX-5461) had an effect on baseline conditions.
Treatments of hippocampal slices for
immunohistochemistry, Real-time PCR and Western blot
analysis
Treatment to detect whether Fsk induced changes in the
expression and distribution of PARP-1 and pADPr
(Fig. 2A). After recovery (see Hippocampal slice preparation
section), slices were subjected to Fsk (50 mM) or left untreated
(rACSF) for 30 min and then collected and prepared for
immunohistochemistry (IHC).
Treatment to detect whether low-dose Act-D caused
nucleolar disruption in mouse hippocampal slices
(Fig. 5). After recovery, slices were treated with Act-D
(100 nM) or left untreated (rACSF only) for 45 min and then
collected and prepared for IHC.
Treatment to detect whether Fsk-induced rRNA and c-jun
gene expression (Fig. 3 and 7N,O) required PAR and Pol I
activity. Fsk stock solution was diluted in a larger volume of
oxygenated rACSF (10 ml) taken from the treatment beaker and
then added back for the final 40 ml of 50 mM working solution.
The addition of Fsk marked the beginning of treatment (T0). To
test whether PAR is required for rRNAs and c-jun expression, 3-
AB solution (100 mM final concentration) was administered to the
appropriate treatment beakers 15 min prior to the addition of Fsk
(Fig. 3). The same 15 min pretreatment protocol was performed
for the Pol I inhibitor CX-5461 (Fig. 7 N,O). Fsk+inhibitor (3-AB
or CX-5461) treated slices were compared with control (no drug)
and Fsk treated slices. 3-AB treated slices remained in the presence
of drugs until the end of Fsk treatment (T30) at which time they
were rapidly transferred from the treatment beakers to beakers
Figure 2. Forskolin (Fsk) induces an increase in nuclear PARP-1 and pADPr; PAR is required for the maintenance of LTP. (A) PARP-1
(top two rows) and pADPr (bottom two rows) are increased after Fsk treatment in hippocampal slices (compare left columns to right columns in A).
Top row: PARP-1 staining (red) of control (Left) and Fsk treated (50 mM, 30 min) slices (Right). Second row: Merged images of PARP-1 and DAPI
nuclear counterstaining (green). Third row: pADPr staining (red) of control (Left) and Fsk treated slices (Right). Bottom row: Merged images of pADPr
and DAPI; Bar in A = 10 mm. (B) Fsk treatment produces a 2.3 fold increase of nuclear PARP-1 and (C), a 1.2 fold increase of nuclear pADPr. (D) Brief
45 min application of PAR inhibitor 3-AB (100 mM) disrupts LTP in the CA1 region of mouse hippocampal slices. (E) Bars represent the quantification
of the change in LTP amplitude 4 h after initiating treatment. Representative fEPSP traces for times a, b and c (from D) appear above bars. Student’s t-
test (B and C). Student-Newman-Keuls test (E); ** = p,0.01.
doi:10.1371/journal.pone.0104364.g002
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containing oxygenated rACSF for a 15 min washout period and
then collected. CX-5461 treated slices remained in the presence of
drugs until the end of Fsk treatment (T30) at which time they were
collected. Control slices remained in the same beakers in the
presence of vehicle (DMSO) in oxygenated rACSF for the
duration of the experiment. At the end of the treatment, the
slices were collected in TRIzol reagent (Invitrogen) and
prepared for RNA isolation and PCR.
Treatment to detect whether Fsk-induced PARP-1 and
pADPr upregulation required PKA and ERK activity (Fig. 8
and 9). Mouse hippocampal slices were prepared as described
above and drug treatments were conducted as summarized in Fig.
S1. After treatment, slices were homogenized and prepared for
Western Blot analysis.
Selection of hippocampal sections for IHC quantification
We analyzed the entire CA1 region (from CA2 to the
subiculum) of the hippocampus as indicated in the text and figure
legends. We performed 10 experiments. Each experiment utilized
a single mouse from which hippocampal slices and microsections
were obtained. To avoid variability in the quantification (Figs. 2
and 4) hippocampal slices from the same mouse were incubated
with or without drugs (refer to Hippocampal slice preparation and
Drug treatment sections above). The comparison control vs
treated was always within the same experiment and not between
experiments. In addition, the IHC for control and treated slices
from the same experiment were done at the same time. Briefly,
mouse hippocampal slices (400 mm thick) were collected and fixed
overnight in 4% paraformaldehyde (PFA). After fixation, the slices
were rinsed with PBS, embedded in a 4% agarose block and
microsectioned to 40 mm using a vibratome. The first two 40 mm
vibratome sections were discarded to eliminate outer layers
containing a high proportion of dead or damaged pyramidal
cells. Then, four or five 40 mm thick sections (without vibratome
artifacts) were selected for IHC. After IHC, the nucleic acid
fluorescent stain DAPI (49,6-diamidino-2- phenylindole) was
observed under the confocal microscope to identify damaged
sections. If cell damage occurred during slice preparation, then
nuclear DAPI staining would become condensed and the nuclei,
pyknotic. Only the sections that had good DAPI staining were
quantified.
IHC for mouse hippocampal slices
IHC of PARP-1 and pADPr detection (Figure 2A). Fsk
treated and untreated (control) hippocampal slices were collected,
fixed and microsectioned as described above. Microsectioned slices
were transferred directly to quenching solution (0.1% Glycine in
PBS) for 10 min, rinsed 2x (10 min) with phosphate buffered saline
(PBS: distilled water, 0.435% NaH2PO4, 0.973% Na2HPO4,
0.9% NaCl, and 0.01% Na Azide; pH 7.4) and transferred to
background suppressor (0.1% Na Borohydride in PBS) for 10 min.
The slices were rinsed with PBS 3x (10 min), incubated in blocking
solution (2% BSA, 0.1% Triton X-100 with 5% Normal Goat
Serum, NGS, in PBS) for 2 h. The slices were then incubated
overnight with primary antibody (AB): anti-pADPr polyclonal
(1:200; Cat # 4366-BPC- 100, Trevigen) or anti-PARP-1
polyclonal diluted in blocking solution (1:200; Cat # sc-7150,
Santa Cruz BioTechnology) or incubated in blocker alone (no
primary AB control or NP). The slices were then rinsed with PBS
3x (10 min) and incubated overnight in secondary AB (Goat Anti-
Rabbit Alexafluor 568; 1:200) in incubation buffer (0.1 M PBS
with 2% BSA and 0.1% Triton X-100) in the presence of DAPI.
The next day slices were rinsed in PBS 4x (10 min), rinsed 1x with
distilled water (5 min) and mounted onto super frost slides.
Fibrillarin detection (Figure 5). Treated (100 nM Act-D,
45 min) and untreated hippocampal slices were collected, fixed
and microsectioned as described above. To expose the fibrillarin
epitope, the 40 mm sections were treated with 10 mM sodium
citrate buffer (pH 9.0) for 30 min at 80uC [17], washed in PBS
(15 min), transferred to quenching solution for 10 min and
incubated in PBS with 0.7% Triton X-100 for 15 min. The slices
were rinsed with PBS 3x (10 min), incubated in blocking solution
(0.1% Triton X-100 with 4% NGS, in PBS) for 2 h and then
incubated overnight in anti-fibrillarin polyclonal AB (1:500; Cat #
ab5821, Abcam) diluted in blocking solution or blocker alone (NP).
Next, the slices were rinsed with PBS 3x (10 min) and incubated
with secondary AB (Goat Anti-Rabbit Alexafluor 488; 1:200
Molecular probes) for 4 hours before being rinsed again with PBS
Figure 3. PAR is required for Fsk-induced synthesis of new rRNAs. (A) Fsk treatment upregulates unedited precursor rRNA (ht rRNA) (black
bar) 1.8 fold in hippocampal slices compared with untreated controls (white bar). This increase is prevented when PAR is blocked by 3-AB (grey bar).
(B) The PARP-1 dependent immediate-early gene c-jun, was used as a positive control. Student’s t-test; * = p,0.05; ** = p,0.01.
doi:10.1371/journal.pone.0104364.g003
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3x (10 min), 1x with distilled water (5 min) and mounted with
antifade (DAPI Fluoromont-G; Southern Biotech).
RNA isolation and reverse transcription
RNA isolation. Total RNA was isolated from individual
hippocampal slices using TRIzol reagent (Invitrogen), precipi-
tated with isopropanol, resuspended and digested with 1 Unit of
DNAse I (Promega) for 30 min at 37uC. The total RNA was re-
purified with TRIzol and re- suspended in 10 ml of DEPC-treated
water. The RNA purity and concentration was assessed by its
260/280 optical density (OD) ratio.
Reverse Transcription. Five microliters of the re-suspended
RNA was used for reverse transcription using the Superscript III
First-Strand Synthesis kit protocol for random hexamers (Invitro-
gen). The cDNA samples were then treated with RNase H for
20 min in order to remove residual RNA. The cDNA concentra-
tion was estimated from the initial OD values assuming 80%
efficiency of the reverse transcription reaction. Each cDNA sample
was diluted to render a 0.3 ng/ml working solution for analysis by
quantitative (real-time) PCR (qPCR).
qPCR for rRNA and c-jun gene expression. Comparative
Ct qPCR was carried out using SYBR-Green RT-PCR Master
Mix detection reagent (Applied Biosystems) and Stratagene’s
Figure 4. Low-dose Actinomycin D (Act-D) treatment dramatically disrupts nucleolar localization of PARP-1 in cultured
hippocampal neurons. DAPI staining (blue; A, B) shows the area of the nucleus. Nomarski images (grey; G and H) show the area of the nuclei
and nucleoli (shown by arrowheads). Low-dose Act-D treatment (100 nM, 45 min) causes nucleolar disruption as indicated by the distribution of
fibrillarin (green). Fibrillarin forms punctate domains of increased intensity under Act-D treatment (compare large arrowheads A,C to small
arrowheads B,D). Under the same treatment PARP-1 (red) exits the nucleolus (compare large arrowheads in E to small arrowheads in F). Bar = 10 mm.
doi:10.1371/journal.pone.0104364.g004
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Mx3000P Real-Time PCR system. The cDNA was generated
using the random hexamer primers provided in Invitrogen’s
Superscript III First Strand Synthesis kit (Life Technologies). We
used 1.5 ng of cDNA as input for each 20 ml PCR reaction. The
final primer concentration was 0.5 mM. In order to quantify
stimulation-dependent changes in target gene expression, samples
were normalized to the housekeeping gene GAPDH, found to be
constitutively abundant in the hippocampus [18]. The primers
used for mouse GAPDH were: mGAPDH F 59-
TTGTGATGGGTGTGAACCACGAGA-39 and mGAPDH R
Figure 5. Low-dose Act-D treatment causes nucleolar disruption in mouse hippocampal slices. (A, B) Fibrillarin staining (green). (D, E)
Fibrillarin+DAPI nuclear counterstaining (blue) merged. (C) Average area of fibrillarin. (F) Average intensity of fibrillarin. Left image column (A, D):
Control slices show cellular distribution of fibrillarin within nucleoli (large arrowheads) with an average area of 6.3 mm2 (C). Right image column (B, E):
Under Act-D treatment (100 nM, 45 min) fibrillarin forms punctate domains (small arrowheads, B and E) with an average area of only 3.1 mm2 (C) and
intensity that is 1.4 times greater than control (F). Image bar = 10 mm; Student’s t-test (C,F) ** = p,0.01.
doi:10.1371/journal.pone.0104364.g005
Figure 6. Low-dose Act-D treatment blocks LTP maintenance. (A) The maintenance of LTP is blocked by low-dose (45 min, 100 nM) Act-D
treatment. (B) Quantification of the change in LTP amplitude 1 and 2 h after initiating Fsk treatment. Representative fEPSP traces for times a, b, and c
(from A) appear above bars. Student-Newman-Keuls test ** = p,0.01.
doi:10.1371/journal.pone.0104364.g006
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Figure 7. The specific Pol I inhibitor CX-5461 causes nucleolar disruption, blocks LTP maintenance and Fsk-induced synthesis of
new rRNA. DAPI staining (blue; A, B,C) shows the area of the nucleus. Nomarski images (grey; G, H,I) show the area of the nuclei and nucleoli
(arrowheads). Application of Pol I specific inhibitor CX-5461 (200 nM) causes nucleolar disruption as indicated by the distribution of fibrillarin (green);
compare A, D to B, E and C, F. (J) After 1 h CX-5461 treatment, the average area of fibrillarin staining became smaller than control (5.5 mm2 and
7.1 mm2 respectively). After 3 h of CX-5461, fibrillarin formed small punctate domains indicative of nucleolar disruption (average area 4.7 mm2). (K) No
changes in the average intensity of fibrillarin staining were observed after CX-5461 application. (L) The maintenance of LTP is blocked by application
of CX-5461 (200 nM) (45 min). (M) Quantification of the changes in LTP amplitude between Fsk and Fsk+CX-5461 groups show significant changes 4
and 5 h after initiating Fsk treatment. CX-5461 alone had no effect on baseline stimulation (left inset). Representative fEPSP traces for times
designated a, b and c in (L) are shown in middle and right inset. N) Fsk treatment upregulates the immediate-early gene c-jun (black bar) in
hippocampal slices compared with untreated controls (white bar). This increase is not affected by Pol I inhibitor CX-5461 (grey bar). O) Fsk treatment
upregulates unedited precursor rRNA (ht rRNA) (black bar) in hippocampal slices compared with untreated controls (white bar). This increase is
prevented when Pol I inhibitor CX-5461 is applied during Fsk treatment (grey bar). Student’s t-test (J,K,N,O). Student-Newman-Keuls test (M). * = p,
0.05; ** = p,0.01; Bar = 10 mm; NS= not significant.
doi:10.1371/journal.pone.0104364.g007
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Figure 8. Forskolin-induced PARP-1 and pADPr increase requires PKA activity. Left column (A, C, E): Representative Western blots used for
quantification shown in right column (B, D, F). Phosphorylation of the PKA pathway substrate S6K was used as a stimulation-dependent positive
control quantified as the ratio of p-S6K to total S6K (A, B). Histone 2B was used as a loading control (C, E). Fsk treatment (black bar) produced an
increase of p-S6K, PARP-1, and pADPr (B, D, and F, respectively). The Fsk induced upregulation of both PARP-1 and pADPr was prevented by the PKA
inhibitor KT5720 (grey bar; B, D, F). The inhibitor alone had no effect on PARP-1 or pADPr levels (striped bar; D, F respectively) compared with basal
controls (white bar; D, F). Student’s t-test (B,D,F); * = p,0.05; ** = p,0.01; NS = not significant.
doi:10.1371/journal.pone.0104364.g008
Nucleolar Integrity Is Required for LTP
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Figure 9. Forskolin-induced increase of PARP-1 and pADPr requires the ERK pathway. Left column (A, C, E): Representative Western blots
used for quantification shown in right column (B, D, F). Phosphorylation of the ERK pathway substrate S6K was used as a stimulation-dependent
positive control quantified as the ratio of p-S6K to total S6K (A, B). Histone 2B was used as a loading control (C, E). Fsk treatment (black bar) produced
an increase of p-S6K, PARP-1, and pADPr (B, D, and F, respectively). The Fsk induced increase was prevented by the ERK inhibitor U0126 (grey bar; B,
D, F). The inhibitor alone had no effect on PARP-1 or pADPr levels (striped bar; D, F respectively) compared with basal controls (white bar; D, F).
Student’s t-test (B,D,F); * = p,0.05; ** = p,0.01; NS = not significant.
doi:10.1371/journal.pone.0104364.g009
Nucleolar Integrity Is Required for LTP
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59-GAGCCCTTCCACAATGCCAAAGTT-39. In order to dis-
tinguish newly synthesized rRNAs from pre-existing rRNAs we
designed primers to a region of heterogeneous pre-rRNA (ht
rRNA) between the internal transcribed spacer 2 (ITS2) and the
28S rRNA. The editing of ITS2 from 28S rRNA is one of the rate
limiting steps in rRNA maturation. ht rRNA: Acc# X82564 ht
rRNA-F 59-GCCGGGTGCCGTCTCTTT-39 and ht rRNA-R
59-TATGCTTAAATTCAGCGGGTCGCC-39. The immediate
early gene, c-jun was employed as an activity-dependent positive
control. Primer sequences were: mouse c-jun F 59-GAACTGCA-
TAGCCAGAACACGCTT-39 and c-jun R 59-
TGAAGTTGCTGAGGTTGGCGTAGA-39. The thermocy-
cling conditions were as follows: 50uC for 5 min (1 cycle), 95uC
for 10 min (1 cycle), 60uC for 1 min (1 cycle), and 95uC for 15 s
followed by 60uC for 1 min (40 cycles). At the end of the protocol,
a dissociation curve analysis was performed to determine the
specificity of amplification with a start temperature of 55uC.
Western blot analysis for PARP-1 and pADPr
quantification. After treatment, individual slices were trans-
ferred to 70 mL ice-cold homogenization buffer (1% SDS (w/v)),
10 mM EDTA, 50 mM Tris, pH 8.1, and one Roche Protease
inhibitor cocktail tablet). An aliquot of the homogenate was taken
for protein quantification using a Pierce BCA Protein Assay Kit
(Thermo Scientific). The homogenates were immediately diluted
(1:1) in 2x sample buffer (0.125M Tris, 5% SDS (w/v), 10% BME
(v/v), 20% glycerol (w/v), 0.01% blue bromophenol (w/v)),
denatured and subjected to 10% SDS-polyacrylamide gel electro-
phoresis. Total protein (15 mg) was loaded into 0.35 cm wells. The
proteins were transferred to nitrocellulose membrane. For anti-
S6K anti-p70 S6Kinase (S6K) and anti-Phospho-p70 S6Kinase
Thr421/Ser424 (p-S6K) the membranes were blocked (1 h) with
5% bovine serum albumin (BSA) in TBS-Tween 20 (TBST)
(20 mM Tris-HCl, pH 7.6, 15 mM NaCl and 0.1% Tween 20).
For anti-pADPr, anti-PARP-1 and anti-Histone2B (anti-H2B)
membranes were blocked (1 h) in 2% BSA and 2% hemoglobin in
TBST. After blocking, the membranes were incubated with
primary AB overnight at 4uC, washed 3x (5 min) with TBST,
incubated with secondary AB in TBST (1 h) and washed 3x
(5 min) with TBST. The membranes were developed with BCIP/
NBT phosphatase substrate (KPL) until the bands showed clearly.
Finally, the membranes were dried, scanned and stored as JPEG
files. The band intensity was quantified using ImageJ software
(http://rsb.info.nih.gov/ij/). The level of pADPr and PARP-1 was
standardized to that of Histone 2B.
Primary ABs: anti- pADPr polyclonal (1:500, Trevigen); anti-
PARP-1 polyclonal H-250 (1:500; Cat # 7150, Santa Cruz,); anti-
p70 S6Kinase (1:1000; AB Kit Cat # 9430, Cell Signaling); anti-
Phospho-p70 S6Kinase Thr421/Ser424 (1:1000; AB Kit Cat #
9430, Cell Signaling); and anti-H2B (1:2000; Cat # 07-371,
Millipore). Secondary AB: anti-rabbit coupled to alkaline-phos-
phatase (1:2000; Cat # A3687, Sigma). BCIP/NBT phosphatase
substrate (KPL) was used as the detection reagent.
Immunocytochemistry (ICC) for primary hippocampal
cultures
Fibrillarin ICC. Cultured neurons were treated with or
without 3-AB (400 mM final, 3 h; Fig. 1A–G) or CX-5461
(200 nM final, 1 h and 3 h; Fig. 7A–I) and then fixed for
10 min in 4% PFA in PBS (pH 7.4). The cultures were washed
with PBS 3x (10 min) and incubated in 1% SDS in PBS (10 min)
to improve nuclear immuno-detection [19]. The cultures were
then washed with PBS 4x (15 min), incubated in blocking solution
(0.1% Triton X-100, 2% NGS in PBS) for 1 h and then incubated
overnight with primary AB (polyclonal anti-fibrillarin AB (1:1000);
Cat # ab5821, Abcam) in blocking solution or blocking alone (NP
control). The cultures were rinsed with PBS 4x (10 min) and then
incubated with secondary AB (GAR 568) for 4 h in darkness. After
secondary AB incubation, the cultures were rinsed with PBS 4x
(10 min), rinsed 2x with distilled water (5 min each), and mounted
with antifade (DAPI Fluoromont-G; Cat # 0100-20; Southern
Biotech).
Double ICC for fibrillarin and PARP-1 (Fig. 4). Cultured
neurons were treated with or without low concentrations of Act-D
(100 nM final) for 60 min and then fixed for 10 min in 4% PFA in
PBS (pH 7.4). The cultures were washed with PBS 3x (10 min)
and incubated in 1% SDS in PBS (10 min) to improve nuclear
immuno-detection [19]. The cultures were then washed with PBS
4x (15 min), incubated in blocking solution (0.1% Triton X-100,
2% NGS in PBS) for 1 h. With the exception of the NP control, all
cells were incubated overnight with primary ABs (mouse anti-
PARP-1 (1:500); Cat #MCA1522G, AbD Serotec and polyclonal
anti-fibrillarin AB (1:1000); Cat # ab5821, Abcam) in blocking
solution. The NP cells were incubated in blocking solution (4%
NGS/PBS, 0.1% Triton X-100) without AB overnight. The
cultures were rinsed with PBS 4x (10 min) and then incubated
with secondary AB (GAR 488 and GAM Biotin 1:200 dilution) for
4 h at room temperature in darkness. After secondary incubation,
the cultures were rinsed with PBS 4x (10 min) and incubated with
Strep Alexa 647 (far red) for 2 h in darkness at room temperature,
rinsed with PBS 4x (10 min), rinsed 2x with distilled water (5 min)
and mounted with antifade (DAPI Fluoromont-G; Cat# 0100-20;
Southern Biotech).
Double ICC for fibrillarin and nucleostemin for
supplementary figure 2 (Fig. S2). Cultured neurons were
treated with or without low concentrations of Act-D (100 nM) for
3 h at 37uC to specifically block RNA polymerase I. After
treatment, the cultures were rinsed with warm 37uC PBS and fixed
for 10 min in 4% PFA in PBS, pH 7.4. Following a 10 min wash
in PBS, cells were permeated with 1% SDS in PBS solution for
10 min. After 4x (15 min) washing cycles with PBS, cells were
incubated in blocking solution for 1 h. The blocking solution was
retrieved and cells were washed with PBS 2x (10 min) following a
1 h of incubation. With the exception of the NP control, all cells
were incubated overnight with the first primary AB, rabbit anti-
antigen [Rp pAb to fibrillarin; Abcam5821 (1:1000)] in blocking
solution. The NP cells were incubated in blocking solution
overnight. The primary AB and NP were retrieved following
overnight incubation and cells were washed with PBS 4x (10 min).
Cells were then incubated overnight with secondary AB, GAR
568, for 4 h in darkness. Cultures were then washed with PBS 4x
(10 min) and incubated in normal rabbit serum for 1 h. Next,
cultures were washed with PBS 3x (10 min) and incubated with
Fab goat anti-rabbit IgG (H+L) (1:160) in 1X PBS, 0.1% Triton
X-100 for 1 h. Cultures were then washed with PBS 4x (10 min)
and incubated overnight with the second primary AB Rp pAB to
nucleostemin, Cat # 70346 Abcam (1:1000)] diluted in blocking
solution (4% NGS/PBS, 0.1% Triton X-100) overnight on rocker.
Following overnight incubation, cultures were washed with PBS 4x
(10 min) and incubated overnight in darkness with GAR (488). On
the next day, cultures were rinsed with PBS 4x (10 min), then with
sterile water 2x (5 min). Cultures were then mounted on slides
with antifade (DAPI Fluoromont-G; Cat # 0100-20; Southern
Biotech) and cured overnight on a flat surface. Slides were then
stored at 220uC until imaging analysis.
Image analysis for fibrillarin, PARP-1, and pADPr
Images were analyzed using Olympus Fluoview ver. 2.1a
(FV10-ASW version 02.01.01.04). All regions of interest (ROIs)
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were drawn and analyzed blind to control and treated conditions.
All images in a given experiment were shot using identical optical
and digital magnification, laser intensities, photomultiplier voltag-
es, and amplifier gains which were selected to give optimal
dynamic range for the experimental conditions without saturation
in any channel. For quantification of average intensity of nucleolar
PARP-1 (see representative Fig. 4) ROIs were determined by the
extent of fibrillarin staining. For Fig. 5C, F and Fig. 1I, J, the area
and average fibrillarin intensity in were quantified using ROIs
determined by the extent of fibrillarin staining. For Fig. 7J, K only
the largest continuous area of fibrillarin staining in each nucleus
was used as an ROI as the fibrillarin would break up into many
smaller punctate regions at later times. For pADPr and PARP-1
(Fig. 2A–C), ROIs were determined from the extent of DAPI
staining and the average intensities of PARP-1 (Fig. 2B) and
pADPr (Fig. 2C) were quantified. Intensity measurements were
taken on a 0-4095 pixel intensity scale and results were averaged
and controls normalized to one. Representative images were
chosen for figures.
Statistics. For all statistical tests a difference between tested
groups was considered significant if the p,0.05. For immunohisto-
chemistry and immunocytochemistry, homoscedastic two tailed t-
tests were performed. For Western Blot and qPCR analysis, two-
tailed paired Student’s t-tests were performed. For electrophysiology,
two-way repeated measure ANOVA and pairwise multiple com-
parison procedure Student-Newman-Keuls analyses were performed
using SigmaStat statistical software (Systat Software. Richmond, CA,
USA). Data in figures was presented as mean 6 SE.
Results
Ribosomal RNA is expressed and processed in the nucleolus, a
subnuclear structure functionally organized around rDNA tran-
scription and ribosomal biogenesis [20]. The morphology of the
nucleolus is inextricably linked to its function. The nucleolus is
organized into three distinct functional compartments—each
corresponding to a specific stage in the synthesis and processing
of rRNAs and their assembly into ribosomes [21,22]. Accordingly,
changes in nucleolar integrity reflect changes in nucleolar function.
PARP-1 is highly abundant in nucleoli and is now known to play
pivotal roles in nucleolar activities such as rRNA processing and
ribosome biogenesis [15]. PARP-1 has been found to be crucial for
the maintenance and transmission of rDNA chromatin structure
and for the proper organization of heterochromatin during
development [14] [23]. Moreover, studies in Drosophila have
demonstrated that in the absence of Drosophila PARP (dPARP)
gene expression, nucleoli themselves fail to form. This disruption
can be rescued, and nucleolar formation restored, with the ectopic
expression of dPARP [24].
In a previous study we showed that PARP-1 activity was
required for the maintenance of long-term synaptic plasticity in
Aplysia, as well as the plasticity evoked upregulation of rRNA [11].
Given the evidence for the importance of PAR to both nucleolar
function and learning and memory, we hypothesized that
epigenetic regulation of rDNA expression by PARP-1 is necessary
for long-term synaptic plasticity and memory in mammals. To
begin the testing of our hypothesis we proceeded to investigate the
relationship of PARP-1 and nucleolar function to long-term
synaptic plasticity in mice.
Inhibition of PAR results in increased intensity of the
nucleolar protein, fibrillarin
We began by asking, what is the effect of PAR inhibition on the
functional integrity of neuronal nucleoli? A hallmark of Pol I
inhibition and nucleoli disruption is the fragmentation of nucleolar
compartments which can be tracked through the localization of
nucleolar proteins such as fibrillarin or nucleostamin. It has been
shown that the nucleolar retention of fibrillarin, a protein involved
in the processing of precursor rRNAs, depends on active rRNA
synthesis by Pol I [25]. In order to examine the relationship of
PAR to functional nucleolar compartments, we applied the PAR
inhibitor, 3-Aminobenzamide (3-AB; 100 mM, 3 h), to dissociated
hippocampal neuron culture (Figure 1). Since dPARP disruption
affects nucleoli formation and ectopic expression of dPARP can
restore nucleolar formation in drosophila [24], we expected, in our
studies, that PAR inhibition would affect nucleoli integrity.
Measuring the average area of fibrillarin as a marker of nucleolar
integrity, we found no significant difference between 3-AB treated
and untreated control cultures (Fig. 1, compare A, C to B, D);
suggesting that PAR inhibition does not substantially affect
nucleolar integrity (Fig. 1I). However, in the same cells we did
find significant changes in the intensity of fibrillarin staining with
3-AB treated cells (Fig. 1, compare G to H) showing about a 60%
increase in average intensity compared to untreated control
(Fig. 1J, Student’s t-test p = 0.0004); suggesting an altered state of
the nucleoli in the presence of 3-AB.
PAR is required for the expression of long-term synaptic
plasticity in mouse hippocampus
PAR inhibition did not produce the substantial and well-defined
structural changes that characterize nucleolar disruption, however,
PARP-1 has been shown to be required for LTF in Aplysia [11].
Therefore, we tested the functional relevance of PAR during LTP.
We examined whether: 1) PARP-1 expression and activity (PAR) is
regulated by mechanisms of synaptic activity in the mouse
hippocampus; and 2) PAR is required for the maintenance of
LTP. To address the first question, we used immunohistochem-
istry (IHC) to determine whether forskolin (Fsk) treatment that
induces LTP in mouse hippocampal slices alters expression and
localization of PARP-1 and pADPr (Fig. 2A). We found that Fsk
(50 mM) treatment caused a dramatic increase in the intensity of
the nuclear localization of both PARP-1 (Fig. 2B, Student’s t-test,
p = 7.41E-20) and pADPr (Fig. 2C, Student’s t-test, p = 3.704E-5)
in CA1 pyramidal cells of mouse hippocampal slices, supporting
the assertion that PARP-1 is regulated by mechanisms linked to
activation of synaptic activation in the mouse hippocampus. In
order to specifically assess the role of PAR in later stages of LTP,
we applied the PAR inhibitor, 3-AB (100 mM, 45 min), 30 min
after Fsk treatment (Fig. 2D,E). We found that late expression
(.3 h) of Fsk-induced LTP is significantly blocked by 3-AB
(Fig. 2E, Student-Newman-Keuls t-test, p = 0.004). These data
indicate a functional requirement of PAR for the persistence of
Fsk-induced LTP.
PAR is required for plasticity-dependent expression of
rRNAs
Next we asked, what is the relationship between stimulation-
dependent PAR and nucleolar function as indicated by rRNA
gene expression? To address this, we measured the expression of
nascent precursor rRNA by quantitative (real-time) PCR in
hippocampal slices treated with Fsk (50 mM, 30 min) in the
presence and absence of 3-AB (100 mM) compared to untreated
control slices (Fig. 3). To differentiate between Fsk-induced rRNAs
and the pre-existing rRNA pool, we designed primers specific for
the heterogeneous (unedited) pre-rRNA transcript (ht rRNA). As a
positive activity-dependent control, we measured the expression of
the immediate early gene (IEG) c-jun, whose inducible expression
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has been shown to be regulated by PARP-1 [13]. We found an
80% increase in ht rRNA levels in Fsk-only treated slices
compared to controls (Fig. 3A, Student’s t-test p = 0.002). In the
presence of 3-AB, the Fsk-induced increase of precursor rRNA
was significantly reduced (Fig. 3A, Student’s t-test p = 0.005). As
expected, c-jun expression was significantly increased in response
to Fsk treatment (Fig. 3B, Student’s t-test p = 0.03)—an upregula-
tion that was suppressed in the presence of 3-AB (Fig. 3B,
Student’s t-test p = 0.02). These results suggest that the nucleolus
participates in the neuronal response to potentiating stimulation
and that plasticity dependent rRNA expression is regulated by
PAR.
Low concentration Actinomycin D treatment disrupts the
nucleolar localization of PARP-1
So far we have shown that PAR is required for the late
expression of LTP (Fig. 3D) and for the stimulation-evoked
upregulation of rRNA (Pol I dependent transcription) (Fig. 3A).
However, it has already been established that inhibition of PAR
also affects IEGs (Pol II dependent expression) during Fsk-induced
LTP (Fig. 3B) and long-term memory formation [13], leaving it
difficult to ascertain whether activity dependent Pol I transcription
is necessary for LTP. In order to focus on nucleolar function
(rRNA synthesis), we employed low concentration of the
transcriptional inhibitor, Actinomycin D (Act-D) (Fig. 4). Numer-
ous studies have demonstrated that low concentrations (8 nM to
800 nM or 0.01 mg ml21 to 1 mg ml21) of Act-D selectively blocks
Pol I directed rDNA transcription while leaving Pol II and Pol III
mediated transcription intact [25–31]; reviewed by [32] and [33].
Employing low dose Act-D (100 nM) treatment in dissociated
hippocampal neuron cultures, we found that a 1 h exposure was
sufficient to cause fibrillarin to concentrate into small punctate
domains indicative of nucleolar disruption (Fig. 4B,D, small
arrowheads). Similar results were obtained using nucleostemin as
a marker of nucleolar integrity (Fig. S2). Low Act-D treatment
dramatically altered the nuclear localization of PARP-1, causing
the protein to vacate nucleoli (compare Fig. 4E, large arrowheads
with 4F, small arrowheads). There was a 32% decrease in the
average intensity of nucleolar PARP-1 staining in Act-D treated
cultures compared with untreated controls (n = 10; Student’s t-test,
p = 7.9E-07). Our observations in primary cultured neurons
concur with a study performed in cell lines where Act-D treatment
caused PARP-1 to leave nucleoli and become dispersed through-
out the nucleus [34]. The dramatic redistribution of PARP-1 out
of the nucleolus and into the nucleoplasm suggests that, under
these conditions, the nucleolar functions of PARP-1 would be
compromised. Taken together, these findings suggest a structure–
function link through which PARP-1 regulates the rRNA
biosynthesis pathway by participating in the functional organiza-
tion of nucleolar compartments.
Low dose Actinomycin D treatment disrupts nucleolar
integrity in mouse hippocampal slices
Having shown acute nucleolar disruption with low dose Act-D
in dissociated hippocampal neuron culture, we next tested the
efficacy of the treatment in pyramidal cells of the CA1 region of
mouse hippocampal slices. As shown in Fig. 5, a 45 min treatment
of Act-D (100 nM) is sufficient to cause fibrillarin to concentrate
into compact punctate domains (small arrowheads Fig. 5B,E)
compared to untreated slices (large arrowheads Fig. 5A,D). This
resulted in a significant decrease in the average area of fibrillarin
staining (Fig. 5C, Student’s t-test p = 3.69E-09). Furthermore, the
decrease in area coincided with a significant increase in fibrillarin
intensity (Fig. 5F, Student’s t-test p = 0.001). While we cannot
exclude the possibility of changes in fibrillarin expression, the
increase in intensity coupled with a reciprocal decrease in area
suggests a change in the distribution of fibrillarin within nucleolar
compartments indicating nucleolar disruption.
Nucleolar integrity is required for late expression of LTP
in mouse hippocampal slices
To determine whether nucleolar integrity is necessary for long-
term synaptic plasticity we used the same treatment protocol as in
the previous experiment (Fig. 5) to temporarily disrupt functional
nucleolar compartments during Fsk-induced LTP (Fig. 6). Appli-
cation of Act-D (100 nM, 45) 15 min before and during Fsk
treatment blocked the persistence of LTP (Fig. 6A). Note that
although Act-D is present during LTP induction, only its late
expression (2 h) was impaired (Fig. 6B, Student-Newman-Keuls
test p = 0.007). These results suggest that nucleolar integrity is
required for long-term synaptic plasticity.
The specific Pol I inhibitor, CX-5461, causes nucleolar
disruption, blocks the maintenance of LTP and reduces
plasticity-dependent expression of rRNA
Act-D disrupts Pol I activity by targeting GC-rich DNA
sequences especially enriched in rDNA promoters [32]. To further
restrict our disruption to nucleolar integrity maintained by Pol I
activity, we employed a second inhibitor, CX-5461, the first
selective inhibitor of Pol I known to directly target the Pol I
multienzyme complex [35–37]. Like Act-D, CX-5461 has also
been shown to cause rapid nucleolar disruption in cell lines [38].
Using cultured hippocampal neurons we found that a 3 h
application of 200 nM CX5461 was sufficient to cause fibrillarin
to concentrate into small punctate domains indicative of nucleolar
fragmentation (Fig. 7C,F). A significant decrease in the average
area of fibrillarin staining was seen as early as 1 h (Fig. 7J,
Student’s t-test p = 0.0002); however, the decrease in area became
particularly marked after 3 h incubation (7J, Student’s t-test,
p = 5.3461028). We also find significant differences in the average
area of fibrillarin staining between 1 h and 3 h groups (7J,
Student’s t-test, p = 0.0183). No significant changes in fibrillarin
intensity were observed (Fig. 7K).
We next examined the functional consequences of CX-5461 on
LTP (Fig. 7 L,M) and plasticity dependent gene expression (Fig. 7
N,O). As we did for the Act-D treatment, CX-5461 (200 nM) was
added 15 min prior to LTP induction and the inhibitor was
maintained for the full 30 min Fsk treatment. The application of
CX-5461 had no effect on the baseline recording of treated slices
(7M, upper left inset); nor did it subtract from the robust response
of slices to forskolin at the onset and early stages of LTP (7L a,b).
Only the very late expression (.4 h) of LTP was affected by the
application of CX-5461 (Fig. 7M, Student-Newman-Keuls test,
(4 h) p= 0.034; (5 h) p = 0.03). To confirm the selectivity and
efficacy of in vitro CX-5461 treatment, we analyzed the Fsk-
inducible expression of Pol II dependent c-jun and Pol I
dependent rRNA (ht rRNA). As expected, Fsk treatment produced
a significant increase in c-jun expression immediately following the
45 min treatment (Fig. 7N, Student’s t-test, p = 0.007). The Pol I
inhibitor CX-5461 had no effect on the Fsk-induced expression of
c-jun mRNA (Fig. 7N; compare black bar with grey bar). In
contrast, the Fsk-evoked increase in rRNA precursor was
significantly reduced (7O; compare black bar to grey bar,
Student’s t-test p = 0.017). These results indicate that nucleolar
integrity—and indeed, rRNA biosynthesis, are required for long-
term synaptic plasticity.
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PARP-1 and pADPr upregulation is dependent upon PKA
activity
Since PAR is required for both the maintenance of Fsk-evoked
LTP and the activity-induced expression of rRNAs, we next asked:
what molecular pathway leads to the upregulation of PARP-1 and
pADPr during LTP? Forskolin is a potent activator of adenylate
cyclase which results in the rapid release of cAMP [39]. Cyclic
AMP-dependent protein kinase A (PKA) together with MAP
Kinase/ERK has been shown to play an essential role in long-
term plasticity and memory consolidation in invertebrates and
mammals [40–43]. Therefore it seemed likely that Fsk treatment
would activate PARP-1 through the same phosphorylation
cascades. To test this hypothesis, we performed a Western blot
analysis of Fsk-treated (50 mM, 30 min) and untreated mouse
hippocampal slices (see Fig. S1). Previously, it was shown that the
ratio of phosphorylated-p70S6 Kinase (p-S6K) to total p70S6K
(S6K) protein increases as a result of Fsk-induced LTP [44].
Therefore, we used the p-S6K/S6K ratio as a positive indicator of
Fsk-induced potentiation (Fig. 8A, B). Consistent with the IHC in
slices (Fig. 2), we found that both PARP-1 protein (Fig. 8C, D
PARP-1, Student’s t-test p= 0.047) and pADPr (Fig. 8E, F
pADPr, Student’s t-test p = 0.029) were significantly elevated in
Fsk treated slices compared to controls. The activity-dependent
increase in both PARP-1 and pADPr was blocked by the addition
of the PKA inhibitor, KT5720 (Fig. 8D PARP-, Student’s t-test
p = 0.038; 8F pADPr, Student’s t-test p = 0.003). These results
indicate that the Fsk–induced upregulation of PARP-1 and pADPr
requires PKA activity.
PARP-1 and pADPr upregulation is dependent upon ERK
activity
To test for the involvement of ERK, we used a similar protocol
to that used for PKA (Fig. S1). As in the previous experiments, we
observed a significant increase in PARP-1 and pADPr following
Fsk treatment (Fig. 9C, D PARP-1, Student’s t-test p= 0.015; 9E,
F pADPr, Student’s t-test p= 0.029). These increases were
effectively blocked in the presence of the ERK inhibitor, U0126
(Fig. 9D PARP-1, Student’s t-test p = 0.022; 9F pADPr, Student’s
t-test p = 0.002). These results indicate that the Fsk–induced
upregulation of PARP-1 and pADPr requires ERK activity.
Discussion
In 1950, Katz and Halstead first proposed that memory
formation required new protein synthesis [1]—a hypothesis that
was not confirmed in mammals, invertebrates, and in vitro models
of memory until decades later [2,45,46]. In order for memories to
become consolidated, new transcription must accompany the new,
activity-dependent translation [5,9]. So far, most efforts to
understand experience-induced changes in neuronal gene expres-
sion have focused on the transcriptional products of RNA
polymerase II (precursor mRNA, snRNA and microRNA). Here
we show for the first time that the consolidation and persistence of
stimulation-evoked plasticity requires nucleolar integrity and
function. In addition, we show that plasticity-dependent upregula-
tion of rRNA synthesis requires PAR.
Developmental biologists have long appreciated the importance
of rRNA metabolism as a driver of cell growth and responsivity to
environmental cues [47]. Transcription of rDNA, rRNA process-
ing, and ribosome assembly all occur in the nucleolus, a
subnuclear structure exquisitely attuned to dynamic growth
demands and cellular stressors; reviewed by [47–49]. Components
of the nucleolus have been found to affect cell regulation in a
variety of ways. For example, the organization of rDNA in the
nucleolus has been shown to affect global chromatin structure and
gene expression throughout the nucleus [50]. PARP-1 has been
found to be essential for the inheritance of rDNA chromatin
structure [14], the processing of precursor rRNAs and their
assembly into ribosomes [15].
Nucleolar function in neuronal plasticity
As observed in cell growth and development, increased
nucleolar activity has been seen to coincide with activity-
dependent plastic changes in a number of learning and memory
models ranging from spatial learning in goldfish [51] to dissociated
primary hippocampal cell culture; reviewed by [52]. Recently it
was shown that neurite outgrowth induced by the neurotrophic
factor, BDNF, is mediated by Pol I driven transcription resulting
in the increased production of ribosomal subunits [53]. In an
earlier study, Jordan and colleagues [54] found that sustained
neuronal activity results in both an increase in nucleoli and their
functional capacity. What was unknown, prior to this study, is that
stimulation-dependent rRNA synthesis is required for the main-
tenance of LTP.
Regulation of rRNA synthesis during long-term synaptic
plasticity
Long-term synaptic plasticity requires a mechanism that can
integrate diverse intracellular signaling cascades to coordinate de
novo transcription and local protein synthesis. In recent years,
epigenetic mechanisms such as acetylation, methylation and PAR
have been found to be crucial for cognitive processes such as
learning and memory; reviewed by Day and Sweatt [55,56].
PARP-1 becomes activated after training in certain memory tasks
and is responsible for the opening of chromatin required for
plasticity-dependent gene expression in invertebrates and mam-
mals [10,12,13]. Among the plasticity-dependent genes already
known to be regulated by PARP-1 are the immediate early genes
such as c-fos and c-jun [13]. Using c-jun as a positive control for
PAR-dependent gene expression, we demonstrate here that
rRNAs are also regulated by PAR during late-phase LTP.
Additionally, we found that the expression and localization of
PARP-1 and PAR, is regulated by a mechanism of synaptic
plasticity—Fsk-induced LTP—via PKA and ERK kinase cascades.
To assess the role of nucleoli in plasticity we disrupted nucleolar
function in three ways: 1) 3-AB treatment which blocked regulated
plasticity-dependent gene expression; 2) low-dose Act-D treatment
which preferentially blocks transcriptional activity at GC–rich
rDNA promoters; and 3) application of the highly specific Pol I
inhibitor, CX-5461, which directly targets the Pol I multi-enzyme
complex [35,37,38]. Each drug treatment was expected to directly
and/or indirectly target ribosomal biogenesis through its rate
limiting step, the production and maturation of rRNA. Each
treatment prevented the maintenance of late-phase LTP.
While ribosomal biogenesis remains the primary function
around which nucleoli take shape, a role for non-ribosomal
functions in plasticity and memory, in addition to the requirement
of new ribosomes, cannot be ruled out. For example, it is known
that a large number of proteins that have no identifiable link to
ribosomal biogenesis accumulate in the nucleolus. It has been
postulated that nucleolar compartments might serve as reservoirs
through which the nuclear concentration of transcription factors
and other ‘‘molecular switches,’’ can be regulated [57]; reviewed
by Hetman and Pietrzak [33].
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Figure 10. Model for the Role of the Nucleolus in Synaptic Activation leading to Long-Term Plasticity. Synaptic stimulation activates
adenylate cyclase (AC) resulting in the rapid release of cAMP and the activation of the cAMPRPKARERK pathway (kinases are indicated in yellow).
Stimuli leading to long-term plasticity activate mTOR dependent protein synthesis of preexisting RNA granules (red ovals) allowing the transition into
late-phase synaptic plasticity. Simultaneously, the cAMPRPKARERK pathway induces the synthesis and activation of chromatin remodeling proteins
(e.g. PARP-1) and new gene expression. It is not yet known whether the mTOR pathway directly contributes to the activation and up-regulation of
PARP-1 (dashed line). PARP-1 opens the chromatin allowing activity-dependent transcription to take place. Among the new genes expressed are
activity-dependent Pol I transcripts required for the consolidation of late-phase synaptic plasticity. In this model, the new stimulation-evoked rRNAs
give rise to new ribosomes. The new plasticity-dependent ribosomes are assembled into new RNA granules (green ovals) and shipped to activated
synapses to maintain, through local protein synthesis, the long-lasting changes required for long-term synaptic plasticity and memory.
doi:10.1371/journal.pone.0104364.g010
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The importance of nucleolar integrity to plasticity and
cognition
Over the past several years, there has been increasing evidence
pointing toward nucleolar impairment as a common denominator
in diseases effecting memory and cognition such as Huntington’s,
Parkinsons’ and Alzheimers’ disease (AD); reviewed by Parlato and
Kreiner, [58]. In an important study by Pietrzak et al., [59], it was
found that the rDNA promoter was hypermethylated in cerebro-
cortical samples from patients diagnosed with Mild Cognitive
Impairment (MCI) and AD compared to controls, suggesting that
epigenetic silencing of rDNA might play a role in the memory
deficits common to the two disorders. Recently, in a study
complementary to ours, it was elegantly demonstrated that long-
term deficits in nucleolar function indeed compromises learning
and memory and that nucleolar integrity is not only neuroprotec-
tive, but required for neuronal homeostasis [60]. Our finding that
acute nucleolar disruption prevents the maintenance of activity-
induced LTP represents a new insight into the molecular
mechanism of long-term plasticity and memory consolidation.
Model for late-phase synaptic plasticity
Here we present a model (Fig. 10) for the transduction of
synaptic stimuli to long-term plasticity beginning with the
activation of the cAMPRPKARERK pathway. This process is
achieved with the activation of mTOR dependent translation of
preexisting RNA granules (red) allowing for the transition from
short-term plasticity to the initial phase of long-term plasticity.
Simultaneously, the cAMPRPKARERK pathway induces the
synthesis and activation of chromatin remodeling proteins
including PARP-1. PARP-1 allows chromatin relaxation and the
transcription of immediate early genes (e.g. c-fos and c-jun) and
late-phase genes require for long-term plasticity. An essential
component of late-phase activity-dependent gene expression is
rRNA biosynthesis, the rate-limiting step in the production of new
ribosomes. Ribosomal biogenesis requires both Pol I driven
transcription and the efficient processing of nascent rRNA
transcripts—two processes now shown to be regulated by PAR.
In this model, new and qualitatively different ribosomes become
assembled into new RNA granules (green) that are shipped to
activated synapses in order to maintain, through local protein
synthesis, the long-lasting changes required to consolidate
memory.
Supporting Information
Figure S1 Drug treatment protocol for PKA and ERK
experiments. For the basal condition control (line A), the slices
were kept in oxygenated ACSF for the duration of the experiment.
The addition of Fsk marked Time 0 (T0) and lasted for 30 min
(line B). For co-treatment with Fsk and inhibitor (KT5720 or
U0126), the inhibitor was added 20 min prior to T0 (line C). As a
negative control, PKA or ERK inhibitors (KT5720 or U0126,
respectively) were applied alone for the duration of the experiment
(line D).
(TIF)
Figure S2 Actinomycin D dramatically disrupts the
nucleolar localization of nucleostemin and fibrillarin in
cultured hippocampal neurons. (A,B) DAPI (blue), fibrillarin
(red), nucleostemin (green). DAPI staining shows the area of the
nucleus. (G, H) Nomarski images (grey) show the area of the nuclei
and nucleoli (arrowheads). Low-dose Act-D treatment (100 nM,
3 h) causes nucleolar disruption as indicated by the distribution of
fibrillarin and nucleostemin (small arrowheads); compare A,C,E to
B,D,F respectively. Bar = 10 mm.
(TIF)
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